Bionova aims to launch commercial manufacturing by 2021 with new biologics plant

Bionova aims to launch commercial manufacturing by 2021 with new biologics plant

Source: 
Fierce Pharma
snippet: 

Bionova already has clinical trial supply on lock, boasting more than 200 biopharma clients. Now, the Bay Area biologics maker aims to beef up commercial production, too, by building a manufacturing facility on its home turf.

Last week, CDMO Bionova Scientific started construction on a biologics plant at its Fremont, California, headquarters. The 36,000-square-foot manufacturing facility will allow Bionova to continue working with its clients past the clinical trial stage. And talks to secure production slots in 2021 are already underway, the company said.